TRANSTHERA SCIENCES (NANJING), INC. - B - H SHARES
(HKEX: 2617)
TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China.
192.000 -
-2.200
(-1.13%)
Range
191.200 - 197.000
(3.03%)
Open
197.000
Previous Close
194.200
Bid Price
192.000
Bid Volume
('000)
6.5
Ask Price
192.600
Ask Volume
('000)
0.5
Volume
('000)
169.7
Value
32,770,312
Remark
-
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
